First keyhole nephrectomy performed using Novare's RealHand products:
This article was originally published in Clinica
Executive Summary
Surgical devices developed by Novare Surgical Systems have permitted what the company claims are the first ever laparoscopic nephrectomy - kidney removal - that left no visible scar. The surgery was performed using Novare's RealHand high dexterity (HD) instruments, which are designed to exactly mirror the surgeon's hand movements. The single incision was made through the patient's navel, leaving no scar. Dr Jeffrey Cadeddu, associate professor of urology and radiology at UT Southwestern Medical Center in Dallas, Texas, performed the surgery. He said: "Surgeons can do a procedure using only one hole, and they can hide the hole in a cosmetically advantageous or less painful location." The instruments received FDA 510(k) clearance in June.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.